Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Forward-Shifted Intravascular Lithotripsy (IVL) Technology in a Prospective, Multi-center, Single-arm Investigational Device Exemption (IDE) Study

NCT05858905 is registered in ClinicalTrials.gov with Shockwave Medical, Inc. as lead sponsor.

NCT NCT05858905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05858905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Forward-Shifted Intravascular Lithotripsy (IVL) Technology in a Prospective, Multi-center, Single-arm Investigational Device Exemption (IDE) Study
Lead sponsor
Shockwave Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
June 27, 2023
Completion date
April 21, 2025
Enrollment
75 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease